CLINICAL TRIAL
What we are doing:
Type 1 diabetes (T1D) is a form of autoimmune disease in which there is an immune attack on the cells that produce insulin, called beta cells. Patients therefore require intensive insulin regimens to control their blood sugar. T1D is usually differentiated from type 2 diabetes by the use of autoantibodies, which are measures of the autoimmune attack on the beta cell. Fewer than 10% of people diagnosed with T1D will end up not having autoantibodies at diagnosis. We are trying to better understand this form of T1D through interrogation of genetic and immune differences.
How to participate:
The University of California San Francisco (UCSF) is looking for patients that have T1D but no autoantibodies. Usually, patients will be informed of this type of diabetes by their endocrinologist or diabetes doctors. Since many patients can access their medical records, the names of the autoantibodies are:
- Insulin autoantibody
- Zinc Transporter 8 antibody
- GAD65 antibody
- IC-512 Antibody
- IA-2 antibody
- Islet cell antibody
We can always help get this figured out if patients are not sure of their status.
If you would like to participate, please complete a secure registration form linked below. One of our team members will be in touch with you soon to schedule a screening phone call.